• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

CADM1/HER2/STAT3 轴在浆液性卵巢肿瘤中的特征及临床意义。

Characterization and clinical significance of the CADM1/HER2/STAT3 axis in serous ovarian tumors.

机构信息

Department of Obstetrics and Gynecology, the Second Affiliated Hospital of University of South China, Hunan.

Institute of Basic Medicine, Hebei Medical University, Shijiazhuang.

出版信息

Medicine (Baltimore). 2021 Feb 26;100(8):e23777. doi: 10.1097/MD.0000000000023777.

DOI:10.1097/MD.0000000000023777
PMID:33663040
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7909124/
Abstract

The subtypes of serous ovarian tumors (SOTs), including benign serous cystadenoma, serous borderline tumor (SBT), low-grade serous ovarian carcinoma (LGSC), and high-grade serous ovarian carcinoma (HGSC), remain poorly understood. Herein, we aimed to characterize the cell adhesion molecule 1 (CADM1)/signal transducer and activator of transcription 3 (STAT3)/human epidermal growth factor receptor 2 (HER2) axis and identify its clinical significance in patients with serous cystadenoma, SBT, LGSC, and HGSC.The immunohistochemical expression of CADM1, HER2, and STAT3 was assessed in 180 SOT specimens, and its association with clinical data was determined.High levels of CADM1 expression were detected in 100% of serous cystadenomas and 83.33% of SBTs, while a loss of CADM1 expression was observed in 44% of LGSCs and 72.5% of HGSCs. Relative to the levels in benign cystadenomas and SBTs, higher levels of HER2 and STAT3 expression were observed in LGSCs and aggressive HGSCs. Furthermore, the expression profile of the CADM1/HER2/STAT3 axis was significantly associated with histologic type, International Federation of Gynecology and Obstetrics stage, and lymph node metastasis in patients with SOT.Our study identified the changes in the CADM1/HER2/STAT3 axis that were closely associated with the clinical behavior of SOTs. These molecular data may provide new insights into SOT carcinogenesis and aid in the diagnosis and treatment of patients with SOT.

摘要

浆液性卵巢肿瘤(SOT)的亚型,包括良性浆液性囊腺瘤、浆液性交界性肿瘤(SBT)、低级别浆液性卵巢癌(LGSC)和高级别浆液性卵巢癌(HGSC),仍然知之甚少。在此,我们旨在描述细胞黏附分子 1(CADM1)/信号转导子和转录激活子 3(STAT3)/人表皮生长因子受体 2(HER2)轴,并确定其在浆液性囊腺瘤、SBT、LGSC 和 HGSC 患者中的临床意义。评估了 180 例 SOT 标本中 CADM1、HER2 和 STAT3 的免疫组织化学表达,并确定了其与临床数据的相关性。在 100%的浆液性囊腺瘤和 83.33%的 SBT 中检测到 CADM1 表达水平升高,而在 44%的 LGSC 和 72.5%的 HGSC 中观察到 CADM1 表达缺失。与良性囊腺瘤和 SBT 相比,LGSC 和侵袭性 HGSC 中 HER2 和 STAT3 的表达水平更高。此外,CADM1/HER2/STAT3 轴的表达谱与 SOT 患者的组织学类型、国际妇产科联合会分期和淋巴结转移显著相关。我们的研究确定了与 SOT 临床行为密切相关的 CADM1/HER2/STAT3 轴的变化。这些分子数据可能为 SOT 发生提供新的见解,并有助于 SOT 患者的诊断和治疗。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9252/7909124/6750415683c6/medi-100-e23777-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9252/7909124/437383a642f7/medi-100-e23777-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9252/7909124/28970f1d80e9/medi-100-e23777-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9252/7909124/6750415683c6/medi-100-e23777-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9252/7909124/437383a642f7/medi-100-e23777-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9252/7909124/28970f1d80e9/medi-100-e23777-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9252/7909124/6750415683c6/medi-100-e23777-g003.jpg

相似文献

1
Characterization and clinical significance of the CADM1/HER2/STAT3 axis in serous ovarian tumors.CADM1/HER2/STAT3 轴在浆液性卵巢肿瘤中的特征及临床意义。
Medicine (Baltimore). 2021 Feb 26;100(8):e23777. doi: 10.1097/MD.0000000000023777.
2
[Expression and clinical relevance of ARHI, STAT3 and E2F1 in ovarian serous carcinoma].ARHI、STAT3和E2F1在卵巢浆液性癌中的表达及临床意义
Zhonghua Zhong Liu Za Zhi. 2008 Dec;30(12):905-9.
3
Clinicopathologic and Molecular Features of Paired Cases of Metachronous Ovarian Serous Borderline Tumor and Subsequent Serous Carcinoma.同期发生的卵巢浆液性交界性肿瘤和随后发生的浆液性癌的临床病理和分子特征。
Am J Surg Pathol. 2019 Nov;43(11):1462-1472. doi: 10.1097/PAS.0000000000001325.
4
Ovarian high-grade serous carcinoma with a noninvasive growth pattern simulating a serous borderline tumor.具有模拟浆液性交界性肿瘤的非侵袭性生长模式的卵巢高级别浆液性癌。
Hum Pathol. 2015 Oct;46(10):1455-63. doi: 10.1016/j.humpath.2015.06.002. Epub 2015 Jun 16.
5
Expression of glucose transporter protein 1 and p63 in serous ovarian tumor.葡萄糖转运蛋白1和p63在浆液性卵巢肿瘤中的表达
J Obstet Gynaecol Res. 2014 Jul;40(7):1925-30. doi: 10.1111/jog.12447.
6
Nicotinamide N-methyltransferase overexpression may be associated with poor prognosis in ovarian cancer.烟酰胺 N-甲基转移酶过表达可能与卵巢癌预后不良相关。
J Obstet Gynaecol. 2021 Feb;41(2):248-253. doi: 10.1080/01443615.2020.1732891. Epub 2020 Apr 14.
7
Evaluation of MTAP immunohistochemistry loss of expression in ovarian serous borderline tumors as a potential marker for prognosis and progression.评估卵巢浆液性交界性肿瘤中 MTAP 免疫组化表达缺失作为潜在的预后和进展标志物。
Ann Diagn Pathol. 2020 Oct;48:151582. doi: 10.1016/j.anndiagpath.2020.151582. Epub 2020 Aug 12.
8
Clinicopathological significance of DEK overexpression in serous ovarian tumors.DEK在浆液性卵巢肿瘤中过表达的临床病理意义
Pathol Int. 2009 Jul;59(7):443-7. doi: 10.1111/j.1440-1827.2009.02392.x.
9
Long-term Behavior of Serous Borderline Tumors Subdivided Into Atypical Proliferative Tumors and Noninvasive Low-grade Carcinomas: A Population-based Clinicopathologic Study of 942 Cases.浆液性交界性肿瘤细分为非典型增生性肿瘤和非浸润性低级别癌的长期行为:一项基于人群的942例临床病理研究
Am J Surg Pathol. 2017 Jun;41(6):725-737. doi: 10.1097/PAS.0000000000000824.
10
[Expression and significance of GLUT-1 and DNA-PKcs in serous ovarian tumors].[葡萄糖转运蛋白1(GLUT-1)和DNA依赖蛋白激酶催化亚基(DNA-PKcs)在浆液性卵巢肿瘤中的表达及意义]
Ai Zheng. 2007 Nov;26(11):1188-93.

引用本文的文献

1
Molecular landscape of borderline ovarian tumours: A systematic review.卵巢交界性肿瘤的分子图谱:一项系统综述。
Open Med (Wars). 2024 Jun 7;19(1):20240976. doi: 10.1515/med-2024-0976. eCollection 2024.
2
CADM2 participates in endometriosis development by influencing the epithelial-mesenchymal transition.CADM2 通过影响上皮-间充质转化参与子宫内膜异位症的发生。
Reprod Sci. 2024 Oct;31(10):3049-3057. doi: 10.1007/s43032-024-01592-x. Epub 2024 May 20.
3
Comprehensive pan-cancer analysis of STAT3 as a prognostic and immunological biomarker.
全面泛癌分析 STAT3 作为预后和免疫生物标志物。
Sci Rep. 2023 Mar 28;13(1):5069. doi: 10.1038/s41598-023-31226-2.
4
The impact of STAT3 and phospho-STAT3 expression on the prognosis and clinicopathology of ovarian cancer: a systematic review and meta-analysis.STAT3 和磷酸化 STAT3 表达对卵巢癌预后和临床病理的影响:系统评价和荟萃分析。
J Ovarian Res. 2021 Nov 18;14(1):164. doi: 10.1186/s13048-021-00918-6.
5
Functional and Clinical Characteristics of Cell Adhesion Molecule CADM1 in Cancer.细胞黏附分子CADM1在癌症中的功能及临床特征
Front Cell Dev Biol. 2021 Jul 30;9:714298. doi: 10.3389/fcell.2021.714298. eCollection 2021.